Status:
COMPLETED
Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Memantine as an add-on therapy to clozapine may improve schizophrenia negative symptoms and cognitive functioning.
Eligibility Criteria
Inclusion
- Under clozapine with negative symptoms
Exclusion
- Pregnancy
- Lactation
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00757978
Start Date
January 1 2006
End Date
March 1 2008
Last Update
December 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903